药品包装新兴技术的回顾:从防伪到绿色解决方案
Krishang Sikaria1, Amatha Sreedevi1, Nandini Srivastava1
1Department of Pharmaceutical Regulatory Affairs and Management, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, 576104, Karnataka, India.
AAPS PharmSciTech
|November 11, 2025
概括
本次审查强调了制药包装方面的进展,重点关注通过创新技术防伪,药物监测,质量保护,可持续性和患者合规性.
科学领域:
- 药品包装科学 药品包装科学
- 药物输送系统 药物输送系统
- 供应链管理 供应链管理
背景情况:
- 假冒药物对全球健康构成重大风险,需要先进的安全功能.
- 保持药物的完整性和患者的坚持是药品分销的关键挑战.
- 越来越多的环境问题推动了对可持续药品包装解决方案的需求.
研究的目的:
- 审查药品包装的最新创新和新兴趋势.
- 探索五个关键领域的进展:防伪,药物监测,质量保护,可持续性和患者合规性.
- 突出新型包装技术在解决制药行业挑战中的作用.
主要方法:
- 关于近期药品包装创新的综合文献综述.
- 对防伪安全技术 (例如标签,数字水印) 的分析.
- 检查用于药物监测 (例如,RFID,指标) 和患者合规性的智能包装解决方案.
主要成果:
- 物理化学标识符和公开/隐蔽特征增强了制药产品真实性验证.
- 射频识别 (RFID) 和色度指标改善了药物监测和安全.
- 新型包装材料和智能系统可提高药品质量保护和患者遵守.
- 环保包装替代品正在获得引力,以减少对环境的影响.
结论:
- 药品包装方面的创新对于打击假冒药物和确保产品完整性至关重要.
- 智能包装技术为供应链安全,患者安全和改善药物坚持提供了巨大的潜力.
- 制药包装的未来在于整合安全,监控,质量保护,可持续性和以患者为中心的功能.
相关概念视频
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
336
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
336
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
242
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
242
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
226
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
226
01:20Modified-Release Drug Delivery Systems: Influencing Factors
215
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
215
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165
01:27Bioplastics
73
Bioplastics derived from microbial processes present a sustainable alternative to conventional petroleum-based plastics. Among these, polyhydroxyalkanoates (PHAs), particularly polyhydroxybutyrates (PHBs), have emerged as prominent candidates due to their biodegradability and biocompatibility. These polymers are synthesized by a variety of bacteria, such as Cupriavidus necator and Pseudomonas putida, which naturally accumulate PHAs as intracellular carbon and energy reserves, especially under...
73